Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model-Reference-Cited by-同舟云学术

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model

Published:2011-09 Issue:1-3 Volume:131 Page:90-95
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Hahn Margaret,Chintoh Araba,Giacca Adria,Xu Li,Lam Loretta,Mann Steve,Fletcher Paul,Guenette Melanie,Cohn Tony,Wolever Tom,Arenovich Tamara,Remington Gary

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference46 articles.

1. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs;Ader;Diabetes,2005

2. Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice;Bell;Br. J. Pharmacol.,2004

3. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes;Bergman;Eur. J. Clin. Invest.,2002

4. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat;Chaouloff;Eur. J. Pharmacol.,1990

5. Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats;Cheng;Auton. Neurosci.,2000

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mutual effects of gestational diabetes and schizophrenia: how can one promote the other?: A review;Medicine;2024-06-21

2. Development of novel tools for dissection of central versus peripheral dopamine D₂-like receptor signaling in dysglycemia;2024-02-23

3. Drug‐Induced Diabetes;Textbook of Diabetes;2024-01-12

4. Metabolic effects of atypical antipsychotics: Molecular targets;Journal of Neuroendocrinology;2023-10-22

5. Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia;CNS Drugs;2023-07